Inicio
  • Diabetes»
  • Guías alimentarias»
  • Tiroides»
  • Dislipidemia y riesgo cardiovascular»
  • Obesidad»
  • Suprarrenales»
  • Hipófisis y neuroendocrinología»
  • Hueso y paratiroides»
  • Endocrinología reproductiva»
Resultado de busqueda: 18 Medio Año Tema Ver
ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. American College of Cardiology/American heart Association 2019 Dislipidemia y riesgo cardiovascular
Enhancing the Value of PCSK9 Monoclonal Antibodies by Identifying Patients Most Likely to Benefit National Lipid Association (NLA) 2019 Dislipidemia y riesgo cardiovascular
Use of Lipoprotein(a) in Clinical Practice: A Biomarker Whose Time Has Come. A Scientific Statement from the National Lipid Association. National Lipid Association (NLA) 2019 Dislipidemia y riesgo cardiovascular
Executive summary American College of Cardiology/American heart Association 2018 Dislipidemia y riesgo cardiovascular
Guideline on the Management of Blood Cholesterol American College of Cardiology/American heart Association 2018 Dislipidemia y riesgo cardiovascular
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. American College of Cardiology/American heart Association 2018 Dislipidemia y riesgo cardiovascular
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease. American College of Cardiology/American heart Association 2018 Dislipidemia y riesgo cardiovascular
American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. American Association of Clinical Endocrinologist (AACE/ACE) 2017 Dislipidemia y riesgo cardiovascular
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel European Society of Cardiology/European Atherosclerosis Society 2017 Dislipidemia y riesgo cardiovascular
Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Canadian Cardiovascular Society 2016 Dislipidemia y riesgo cardiovascular
ESC/EAS Guidelines for the Management of Dyslipidaemias European Society of Cardiology/European Atherosclerosis Society 2016 Dislipidemia y riesgo cardiovascular
European Guidelines on cardiovascular disease prevention in clinical practice. European Society of Cardiology/European Atherosclerosis Society 2016 Dislipidemia y riesgo cardiovascular
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults. US Preventive Services Task Force (USPSTF) 2016 Dislipidemia y riesgo cardiovascular
An International Atherosclerosis Society Position Paper: Global Recommendations for the Management of Dyslipidemia European Society of Cardiology/European Atherosclerosis Society 2015 Dislipidemia y riesgo cardiovascular
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel. European Society of Cardiology/European Atherosclerosis Society 2015 Dislipidemia y riesgo cardiovascular
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report National Lipid Association (NLA) 2015 Dislipidemia y riesgo cardiovascular
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2 National Lipid Association (NLA) 2015 Dislipidemia y riesgo cardiovascular
ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. European Society of Cardiology/European Atherosclerosis Society 2014 Dislipidemia y riesgo cardiovascular

SMNE

La Sociedad Mexicana de Nutrición y Endocrinología (SMNE), es una asociación civil cuya misión es fomentar el conocimiento de la Nutrición y Endocrinología de sus agremiados para que la prevención y la atención de enfermedades endócrinas y de la nutrición sean ejercidas con calidad y excelencia.